Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 63,573 |
|
|||||
| News | - | ||||||
| Day High | 1.08 | Low High |
|||||
| Day Low | 1.01 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Xilio Therapeutics Inc | XLO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.025 | -2.36% | 1.035 | 11:24:33 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.05 | 1.01 | 1.08 | 1.06 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 187 | 63,573 | $ 1.04 | $ 65,908 | - | 0.49 - 3.40 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 11:24:33 | 100 | $ 1.035 | USD |
Xilio Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 28.92M | 27.54M | - | 0 | -76.4M | -2.77 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Xilio Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical XLO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.22 | 1.28 | 1.01 | 1.11 | 298,873 | -0.185 | -15.16% |
| 1 Month | 1.92 | 1.93 | 1.01 | 1.27 | 3,594,083 | -0.885 | -46.09% |
| 3 Months | 0.6369 | 1.93 | 0.5001 | 1.21 | 1,288,459 | 0.3981 | 62.51% |
| 6 Months | 1.93 | 2.8938 | 0.49 | 1.15 | 681,813 | -0.895 | -46.37% |
| 1 Year | 3.16 | 3.40 | 0.49 | 1.18 | 347,748 | -2.13 | -67.25% |
| 3 Years | 15.00 | 27.95 | 0.49 | 2.74 | 187,301 | -13.97 | -93.10% |
| 5 Years | 15.00 | 27.95 | 0.49 | 2.74 | 187,301 | -13.97 | -93.10% |
Xilio Therapeutics Description
| Xilio Therapeutics Inc is a biotechnology company focused on harnessing the immune system to achieve deep and durable clinical responses to improve the lives of patients with cancer. Leveraging the GPS platform, they are building a pipeline of tumor-selective cytokine and checkpoint inhibitor immunotherapies to treat cancer. The goal is to overcome the limitations of current I-O therapies by developing products with an improved therapeutic index. |
